How many clinical trials are running for mavacamten?

ClinicalTrials.gov currently lists 14 phase 2–4 mavacamten trials: 4 phase 2, 6 phase 3, and 4 phase 4. 1 are actively recruiting.

Are there clinical trials for Camzyos?

Camzyos is the brand name for mavacamten, so mavacamten trials on ClinicalTrials.gov cover it. ClinicalTrials.gov currently lists 14 phase 2–4 mavacamten trials: 4 phase 2, 6 phase 3, and 4 phase 4. 1 are actively recruiting.

Where does this data come from?

All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.

Can I compare mavacamten against other drugs?

Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Cardiomyopathy & ATTR amyloidosis · Live ClinicalTrials.gov data

Mavacamten (Camzyos) clinical trial pipeline

ClinicalTrials.gov lists 14 phase 2–4 trials for mavacamten (Camzyos), 1 of them actively recruiting. Refreshed daily. Add up to four competitors to compare pipelines side by side.

Phase 2–4 trials

Phase 3 trials

Actively recruiting

1,807

Participants across trials

Bristol-Myers Squibb

Lead sponsor by trial count

mavacamten (14)5 active2018–2029

Hide completed

mavacamten

Key

Actual date

Anticipated

Forecast to primary completion

RecruitingActive, not recruitingNot yet recruitingCompleted

'18

'19

'20

'21

'22

'23

'24

'25

'26

'27

'28

'29

mavacamten

MAVERICK-HCMP2

PIONEER-OLEP2

EXPLORER-HCMP3

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCMP2

VALOR-HCMP3

EMBARK-HFpEFP2

A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCMP3

HORIZON-HCMP3

ODYSSEY-HCMP3

MEMENTOP4

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic CardiomyopathyP3

A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)P4

BRAVE-HCMP4

CMI-SWITCHP4

Upcoming readouts

2 ahead · mavacamten

Select a trial to load its full ClinicalTrials.gov record.

Key mavacamten trials

Top 12 of the 14 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

Trial	Title	Phase	Status	Primary completion
NCT07600177	CMI-SWITCH: Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy	Phase 4	Recruiting	Dec 2026
NCT07103655	BRAVE-HCM: The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventr…	Phase 4	Not yet recruiting	Jul 2026
NCT06112743	MEMENTO: A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic O…	Phase 4	Active, not recruiting	Jul 2026
NCT07004972	A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)	Phase 4	Active, not recruiting	Dec 2027
NCT06253221	A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomy…	Phase 3	Active, not recruiting	Nov 2025
NCT03470545	EXPLORER-HCM: Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrop…	Phase 3	Completed	Mar 2020
NCT04349072	VALOR-HCM: A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for S…	Phase 3	Completed	Feb 2022
NCT05174416	A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obs…	Phase 3	Completed	Mar 2023
NCT05414175	HORIZON-HCM: A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy	Phase 3	Completed	Nov 2023
NCT05582395	ODYSSEY-HCM: A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy	Phase 3	Completed	Mar 2025
NCT03442764	MAVERICK-HCM: A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyop…	Phase 2	Completed	Jan 2020
NCT03496168	PIONEER-OLE: Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Card…	Phase 2	Completed	Nov 2023

Track mavacamten with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track mavacamten

Compare mavacamten vs aficamten Compare mavacamten vs acoramidis

FAQ

How many clinical trials are running for mavacamten?: ClinicalTrials.gov currently lists 14 phase 2–4 mavacamten trials: 4 phase 2, 6 phase 3, and 4 phase 4. 1 are actively recruiting.
Are there clinical trials for Camzyos?: Camzyos is the brand name for mavacamten, so mavacamten trials on ClinicalTrials.gov cover it. ClinicalTrials.gov currently lists 14 phase 2–4 mavacamten trials: 4 phase 2, 6 phase 3, and 4 phase 4. 1 are actively recruiting.
Where does this data come from?: All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare mavacamten against other drugs?: Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.

Upcoming readouts

Key mavacamten trials

Track mavacamten with ComplyRx

Related drug pipelines

FAQ

Be the first to access ComplyRx